Market Cap (In CNY)
2.83 Billion
Revenue (In CNY)
1.21 Billion
Net Income (In CNY)
11.58 Million
Avg. Volume
2.04 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.96-19.51
- PE
- -
- EPS
- -
- Beta Value
- 0.061
- ISIN
- CNE100002Y25
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Cheng Zhi Yao
- Employee Count
- -
- Website
- https://www.menovopharm.com
- Ipo Date
- 2017-04-10
- Details
- Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.
More Stocks
-
PEO
-
016360Samsung Securities Co., Ltd.
016360
-
OSCROscar Health, Inc.
OSCR
-
CNBN
-
CHMG
-
RANASUGRana Sugars Limited
RANASUG
-
HAA1
-
SINTERCOMSintercom India Limited
SINTERCOM